Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2020 Volume 20 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

Receptor tyrosine kinase ligands and inflammatory cytokines cooperatively suppress the fibrogenic activity in temporomandibular‑joint‑derived fibroblast‑like synoviocytes via mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase

  • Authors:
    • Shikino Matsumoto
    • Seiji Yokota
    • Naoyuki Chosa
    • Seiko Kyakumoto
    • Hitomichi Kimura
    • Masaharu Kamo
    • Kazuro Satoh
    • Akira Ishisaki
  • View Affiliations / Copyright

    Affiliations: Division of Cellular Biosignal Sciences, Department of Biochemistry, Iwate Medical University, Iwate 028‑3694, Japan, Division of Orthodontics, Department of Developmental Oral Health Science, Iwate Medical University, Iwate 020‑8505, Japan
    Copyright: © Matsumoto et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 1967-1974
    |
    Published online on: June 25, 2020
       https://doi.org/10.3892/etm.2020.8944
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Osteoarthritis (OA)-related fibrosis is a possible cause of temporomandibular joint (TMJ) stiffness. However, the molecular mechanisms underlying the fibrogenic activity in fibroblast‑like synoviocytes (FLSs) remain to be clarified. The present study examined the effects of receptor tyrosine kinase (RTK) ligands, such as fibroblast growth factor (FGF)‑1 and epidermal growth factor (EGF), on myofibroblastic differentiation of the FLS cell line FLS1, which is derived from the mouse TMJ. The present study revealed that both FGF‑1 and EGF dose‑dependently suppressed the expression of the myofibroblast (MF) markers, including α‑smooth muscle actin (α‑SMA) and type I collagen, in FLS1 cells. Additionally, both FGF‑1 and EGF activated extracellular signal‑regulated kinase (ERK) in FLS1 cells. In addition, the mitogen‑activated protein kinase (MAPK)/ERK kinase (MEK) inhibitor U0126 abrogated the FGF‑1‑ and EGF‑mediated suppression of MF marker expression. On the other hand, inflammatory cytokines, such as interleukin‑1β and tumor necrosis factor‑α, also suppressed the expression of MF markers in FLS1 cells. Importantly, U0126 abrogated the inflammatory cytokine‑mediated suppression of MF marker expression. Interestingly, RTK ligands and inflammatory cytokines additively suppressed the expression of type I collagen. These results suggested that RTK ligands and inflammatory cytokines cooperatively inhibited the fibrogenic activity in FLSs derived from the TMJ in a MEK/ERK‑dependent manner. The present findings partially clarify the molecular mechanisms underlying the development of OA‑related fibrosis in the TMJ and may aid in identifying therapeutic targets for this condition. Additionally, FGF‑1 and EGF could be therapeutically utilized to prevent OA‑related fibrosis around the inflammatory TMJ.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Ibi M: Inflammation and temporomandibular joint derangement. Biol Pharm Bull. 42:538–542. 2019.PubMed/NCBI View Article : Google Scholar

2 

Wang XD, Zhang JN, Gan YH and Zhou YH: Current understanding of pathogenesis and treatment of TMJ osteoarthritis. J Dent Res. 94:666–673. 2015.PubMed/NCBI View Article : Google Scholar

3 

Dijkgraaf LC, Liem RS and de Bont LG: Synovial membrane involvement in osteoarthritic temporomandibular joints: A light microscopic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 83:373–386. 1997.PubMed/NCBI View Article : Google Scholar

4 

Dijkgraaf LC, Liem RS and de Bont LG: Ultrastructural characteristics of the synovial membrane in osteoarthritic temporomandibular joints. J Oral Maxillifac Surg. 55:1269–1279. 1997.PubMed/NCBI View Article : Google Scholar

5 

Dijkgraaf LC, Zardeneta G, Cordewener FW, Liem RS, Schmitz JP, de Bont LG and Milam SB: Crosslinking of fibrinogen and fibronectin by free radicals: A possible initial step in adhesion formation in osteoarthritis of the temporomandibular joint. J Oral Maxillofac Surg. 61:101–111. 2003.PubMed/NCBI View Article : Google Scholar

6 

Yokota S, Chosa N, Kyakumoto S, Kimura H, Ibi M, Kamo M, Satoh K and Ishisaki A: ROCK/actin/MRTF signaling promotes the fibrogenic phenotype of fibroblast-like synoviocytes derived from the temporomandibular joint. Int J Mol Med. 39:799–808. 2017.PubMed/NCBI View Article : Google Scholar

7 

Chen TM, Chen YH, Sun HS and Tsai SJ: Fibroblast growth factors: Potential targets for regenerative therapy of osteoarthritis. Chin J Physiol. 62:2–10. 2019.PubMed/NCBI View Article : Google Scholar

8 

Beenken A and Mohammadi M: The fgf family: Biology, pathophysiology and therapy. Nat Rev Drug Discov. 8:235–253. 2009.PubMed/NCBI View Article : Google Scholar

9 

Liu F and Zhuang S: Role of receptor tyrosine kinase signaling in renal fibrosis. Int J Mol Sci. 17(E972)2016.PubMed/NCBI View Article : Google Scholar

10 

Omitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Couller F, Gao G and Goldfarb M: Receptor specificity of the fibroblast growth factor family. J Biol Chem. 271:15292–15297. 1996.PubMed/NCBI View Article : Google Scholar

11 

Raju R, Palapetta SM, Sandhya VK, Sahu A, Alipoor A, Balakrishnan L, Advani J, George B, Kini KR, Geetha NP, et al: A network map of FGF-1/FGFR signaling system. J Signal Transduct. 2014(962962)2014.PubMed/NCBI View Article : Google Scholar

12 

Zhu L, Weng Z, Shen P, Zhou J, Zeng J, Weng F, Zhang X and Yang H: S100B regulates inflammatory response during osteoarthritis via fibroblast growth factor receptor 1 signaling. Mol Med Rep. 18:4855–4864. 2018.PubMed/NCBI View Article : Google Scholar

13 

Cohen S and Elliott GA: The stimulation of epidermal keratinization by a protein isolated from the submaxillary gland of the mouse. J Invest Dermatol. 40:1–5. 1963.PubMed/NCBI View Article : Google Scholar

14 

Tsai CJ and Nussinov R: Emerging mechanism of EGFR activation in physiological and pathological contexts. Biophys J. 117:5–13. 2019.PubMed/NCBI View Article : Google Scholar

15 

Lemmmon MA and Schlessinger J: Cell signaling by receptor tyrosine kinase. Cell. 141:1117–1134. 2010.PubMed/NCBI View Article : Google Scholar

16 

Dawnward J, Waterfield MD and Parker PJ: Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. J Biol Chem. 260:14538–14546. 1985.PubMed/NCBI

17 

Helin K, Velu T, Martin P, Vass WC, Allevato G, Lowy DR and Beguinot L: The biological activity of the human epidermal growth factor receptor is positively regulated by its C-terminal tyrosines. Oncogene. 6:825–832. 1991.PubMed/NCBI

18 

Wee P and Wang Z: Epidermal growth factor receptor cell proliferation signaling pathways. Cancers (Basel). 9(E52)2017.PubMed/NCBI View Article : Google Scholar

19 

Ren G, Lutz L, Raiton P, Wiley JP, McAllister J, Powell J and Krawetz RJ: Serum and synovial fluid cytokine profiling in hip osteoarthritis: Distinct from knee osteoarthritis and correlated with pain. BMC Musculoskelet Disord. 19(39)2018.PubMed/NCBI View Article : Google Scholar

20 

Jia H, Ma X, Tong W, Doyran B, Sun Z, Wang L, Zhang X, Zhou Y, Badar F, Chandra A, et al: EGFR signaling is critical for maintaining the superficial layer of articular cartilage and preventing osteoarthritis initiation. Proc Natl Acad Sci USA. 113:14360–14365. 2016.PubMed/NCBI View Article : Google Scholar

21 

Wojdasiewicz P, Poniatowski ŁA and Szukiewicz D: The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014(561459)2014.PubMed/NCBI View Article : Google Scholar

22 

Boraschi D and Tagliabue A: The interleukin-1 receptor family. Semin Immunol. 25:394–407. 2013.PubMed/NCBI View Article : Google Scholar

23 

MacEwan DJ: TNF receptor subtype signaling: Differences and cellular consequences. Cell Signal. 14:477–492. 2002.PubMed/NCBI View Article : Google Scholar

24 

Shin JM, Kang JH, Lee SA, Park IH and Lee HM: Baicalin downregulates IL-1β-stimulated extracellular matrix production in nasal fibroblasts. PLoS One. 11(e0168195)2016.PubMed/NCBI View Article : Google Scholar

25 

Hou J, Ma T, Cao H, Chen Y, Wang C, Chen X, Xiang Z and Han X: TNF-α induced NF-κB activation promotes myofibroblast differentiation of LR-MSCs and exacerbates bleomycin-induced pulmonary fibrosis. J Cell Physiol. 233:2409–2419. 2018.PubMed/NCBI View Article : Google Scholar

26 

Mia MM and Bank RA: The IκB kinase inhibitor strongly attenuates TGFβ1-induced myofibroblast formation and collagen synthesis. J Cell Mol Med. 19:2780–2792. 2015.PubMed/NCBI View Article : Google Scholar

27 

Liu X, Kelm RJ Jr and Strauch AR: Transforming growth factor beta1-mediated activation of the smooth muscle alpha-actin gene in human pulmonary myofibroblasts is inhibited by tumor necrosis factor-alpha via mitogen-activated protein kinase 1-dependent induction of the Egr-1 transcriptional repressor. Mol Biol Cell. 20:2174–2185. 2009.PubMed/NCBI View Article : Google Scholar

28 

Harmer NJ: Insights into the role of heparin sulphate in fibroblast growth factor signaling. Biochem Soc Trans. 34:442–445. 2006.PubMed/NCBI View Article : Google Scholar

29 

Bernasconi G, Marchetti C, Reguzzoni M and Baciliero U: Synovia hyperplasia and calcification in the human TMJ disk: A clinical, surgical, and histologic study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 84:245–252. 1997.PubMed/NCBI View Article : Google Scholar

30 

Hildebrand KA, Zhang M and Hart DA: Myofibroblast upregulators are elevated in joint capsules in posttraumatic contractures. Clin Orthop Relat Res. 456:85–91. 2007.PubMed/NCBI View Article : Google Scholar

31 

Hildebrand KA, Zhang M, van Snellenberg W, King GJ and Hart DA: Myofibroblast numbers are elevated in human elbow capsules after trauma. Clin Orthop Relat Res. 189–197. 2004.PubMed/NCBI View Article : Google Scholar

32 

Hinz B, Phan SM, Thannickal VJ, Plunotto M, Desmouliére A, Varga J, De Wever O, Mareel M and Gabbiani G: Recent developments in myofibroblast biology: Paradigms for connective tissue remodeling. Am J Pathol. 180:1340–1355. 2012.PubMed/NCBI View Article : Google Scholar

33 

van Caam A, Vonk M, van den Hoogen F, van Lent P and van der Kraan P: Unraveling SSc pathophysiology; The myofibroblast. Front Immunol. 9(2452)2018.PubMed/NCBI View Article : Google Scholar

34 

Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML and Gabbiani G: The myofibroblast: one function, multiple organs. Am J Pathol. 170:1807–1816. 2007.PubMed/NCBI View Article : Google Scholar

35 

Kimura H, Okubo N, Chosa N, Kyakumoto S, Kamo M, Miura H and Ishisaki A: EGF positively regulates the proliferation and migration, and negatively regulates myofibroblast differentiation of periodontal ligament-derived endothelial progenitor cells through MEK/ERK- and JNK-dependent signals. Cell Physiol Biochem. 32:899–914. 2013.PubMed/NCBI View Article : Google Scholar

36 

Lee HR, Lee J and Kim HJ: Differential effects of MEK inhibitor on rat neural stem cell differentiation: Repressive roles of MEK2 in neurogenesis and induction of astrocytogenesis by PD98059. Pharmacol Res. 149(104466)2019.PubMed/NCBI View Article : Google Scholar

37 

Ma L, Lan F, Zheng Z, Xie F, Wang L, Liu W, Han J, Zheng F, Xie Y and Huang Q: Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion. Mol Cancer. 11(79)2012.PubMed/NCBI View Article : Google Scholar

38 

Ziv E, Rotem C, Miodovnik M, Ravid A and Koren R: Two modes of ERK activation by TNF in keratinocytes: Different cellular outcomes and bi-directional modulation by vitamin D. J Cell Biochem. 104:606–619. 2008.PubMed/NCBI View Article : Google Scholar

39 

Kakiashvili E, Dan Q, Vandermeer M, Zhang Y, Waheed F, Pham M and Száski K: The epidermal growth factor receptor mediates tumor necrosis factor-alpha-induced activation of the ERK/GEF-H1/RhoA pathway in tubular epithelium. J Biol Chem. 286:9268–9279. 2011.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Matsumoto S, Yokota S, Chosa N, Kyakumoto S, Kimura H, Kamo M, Satoh K and Ishisaki A: Receptor tyrosine kinase ligands and inflammatory cytokines cooperatively suppress the fibrogenic activity in temporomandibular‑joint‑derived fibroblast‑like synoviocytes via mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase. Exp Ther Med 20: 1967-1974, 2020.
APA
Matsumoto, S., Yokota, S., Chosa, N., Kyakumoto, S., Kimura, H., Kamo, M. ... Ishisaki, A. (2020). Receptor tyrosine kinase ligands and inflammatory cytokines cooperatively suppress the fibrogenic activity in temporomandibular‑joint‑derived fibroblast‑like synoviocytes via mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase. Experimental and Therapeutic Medicine, 20, 1967-1974. https://doi.org/10.3892/etm.2020.8944
MLA
Matsumoto, S., Yokota, S., Chosa, N., Kyakumoto, S., Kimura, H., Kamo, M., Satoh, K., Ishisaki, A."Receptor tyrosine kinase ligands and inflammatory cytokines cooperatively suppress the fibrogenic activity in temporomandibular‑joint‑derived fibroblast‑like synoviocytes via mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase". Experimental and Therapeutic Medicine 20.3 (2020): 1967-1974.
Chicago
Matsumoto, S., Yokota, S., Chosa, N., Kyakumoto, S., Kimura, H., Kamo, M., Satoh, K., Ishisaki, A."Receptor tyrosine kinase ligands and inflammatory cytokines cooperatively suppress the fibrogenic activity in temporomandibular‑joint‑derived fibroblast‑like synoviocytes via mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase". Experimental and Therapeutic Medicine 20, no. 3 (2020): 1967-1974. https://doi.org/10.3892/etm.2020.8944
Copy and paste a formatted citation
x
Spandidos Publications style
Matsumoto S, Yokota S, Chosa N, Kyakumoto S, Kimura H, Kamo M, Satoh K and Ishisaki A: Receptor tyrosine kinase ligands and inflammatory cytokines cooperatively suppress the fibrogenic activity in temporomandibular‑joint‑derived fibroblast‑like synoviocytes via mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase. Exp Ther Med 20: 1967-1974, 2020.
APA
Matsumoto, S., Yokota, S., Chosa, N., Kyakumoto, S., Kimura, H., Kamo, M. ... Ishisaki, A. (2020). Receptor tyrosine kinase ligands and inflammatory cytokines cooperatively suppress the fibrogenic activity in temporomandibular‑joint‑derived fibroblast‑like synoviocytes via mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase. Experimental and Therapeutic Medicine, 20, 1967-1974. https://doi.org/10.3892/etm.2020.8944
MLA
Matsumoto, S., Yokota, S., Chosa, N., Kyakumoto, S., Kimura, H., Kamo, M., Satoh, K., Ishisaki, A."Receptor tyrosine kinase ligands and inflammatory cytokines cooperatively suppress the fibrogenic activity in temporomandibular‑joint‑derived fibroblast‑like synoviocytes via mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase". Experimental and Therapeutic Medicine 20.3 (2020): 1967-1974.
Chicago
Matsumoto, S., Yokota, S., Chosa, N., Kyakumoto, S., Kimura, H., Kamo, M., Satoh, K., Ishisaki, A."Receptor tyrosine kinase ligands and inflammatory cytokines cooperatively suppress the fibrogenic activity in temporomandibular‑joint‑derived fibroblast‑like synoviocytes via mitogen‑activated protein kinase kinase/extracellular signal‑regulated kinase". Experimental and Therapeutic Medicine 20, no. 3 (2020): 1967-1974. https://doi.org/10.3892/etm.2020.8944
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team